New Oral Antihistamines in Pediatrics

Pediatric Emergency Care

Volumn 20, Issue 2, 2004, Pages 143-147

  Horowitz, Russ ^a   Reynolds, Sally ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Allergic rhinitis; Atopic dermatitis; Histamine; Urticaria

Indexed keywords

ANTIHISTAMINIC AGENT; ASTEMIZOLE; CETIRIZINE; CHLORPHENIRAMINE; CHLORPHENIRAMINE MALEATE; DESLORATADINE; DIPHENHYDRAMINE; FEXOFENADINE; HYDROXYZINE; LORATADINE; PROMETHAZINE; TERFENADINE;

AGITATION; ALLERGIC RHINITIS; ALLERGY; ATOPIC DERMATITIS; CARDIOTOXICITY; CHILD; COGNITIVE DEFECT; DRY EYE; FATIGUE; HEARING IMPAIRMENT; HUMAN; HYPERTENSION; INTELLECTUAL IMPAIRMENT; MOTOR DYSFUNCTION; QT PROLONGATION; REVIEW; RISK BENEFIT ANALYSIS; SEDATION; SIDE EFFECT; TACHYCARDIA; TORSADE DES POINTES; URTICARIA; VISUAL IMPAIRMENT; XEROSTOMIA;

ADMINISTRATION, ORAL; CHILD; DERMATITIS, ATOPIC; HISTAMINE H1 ANTAGONISTS; HUMANS; RHINITIS; URTICARIA;

EID: 1242338907     PISSN: 07495161     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pec.0000113886.10140.9e     Document Type: Review

References (65)

1. Casale TB, Rodbard D, Kaliner M. Characterization of histamine H-1 receptors on human peripheral lung. Biochem Pharmacol. 1985;34(18): 3285-3292.
2. Hill SJ, Emson PC, Young JM. The binding of [3H]mepyramine to histamine H1 receptors in guinea-pig brain. J Neurochem. 1978;31(4): 997-1004.
3. Hide M, et al. Histamine H1-receptor in endothelial and smooth muscle cells of guinea-pig aorta. Eur J Pharmacol. 1988;148(2):161-169.
4. Hill SJ, Young YM. Characterization of [3H]mepyramine binding to the longitudinal muscle of guinea pig small intestine. Mol Pharmacol. 1981;19(3):379-387.
5. Jeannin P, et al. Histamine induces interleukin-8 secretion by endothelial cells. Blood. 1994;84(7):2229-2233.
6. Cameron W, Doyle K, Rocklin RE. Histamine type 1 (H1) receptor radioligand binding studies on normal T cell subsets, B cells, and monocytes. J Immunol. 1986;136(6):2116-2120.
7. Villemain FM, Bach JF, Chatenoud LM. Characterization of histamine H1 binding sites on human T lymphocytes by means of 1251-iodobolpyramine. Preferential expression of H1 receptors on CD8 T lymphocytes. J Immunol. 1990;144(4):1449-1454.
8. White MV. The role of histamine in allergic diseases. J Allergy Clin Immunol. 1990;86(4 Pt 2):599-605.
9. White MV, Slater JE, Kaliner MA. Histamine and asthma. Am Rev Respir Dis. 1987;135(5):1165-1176.
10. Limon L, Kockler DR. Desloratadine: a nonsedating antihistamine. Ann Pharmacother. 2003;37(2):237-246;quiz 313-316.
11. Katcher ML. Cold, cough, and allergy medications: uses and abuses. Pediatr Rev. 1996;17(1):12-17.
12. Larsen JS. Do antihistamines have a role in asthma therapy? Pharmacotherapy. 2001;21(3 Pt 2):28S-33S.
13. Ash AS, Schild HO. Receptors mediating some actions of histamine. Br J Pharmacol. 1966;27(2):427-439.
14. Black JW, et al. Definition and antagonism of histamine H2-receptors. Nature. 1972;236(5347):385-390.
15. Arrang JM. Pharmacological properties of histamine receptor subtypes. Cell Mol Biol (Noisy-le-grand). 1994;40(3):275-281.
16. Simons FE, Simons KJ. The pharmacology and use of H1-receptor-antagonist drugs. N Engl J Med. 1994;330(23):1663-1670.
17. Roth T, et al. Sedative effects of antihistamines. J Allergy Clin Immunol. 1987;80(1):94-98.
18. Warren RA, et al. Analysis of fatal traffic crashes in Canada, 1977-1978: focus: the impaired driver. TIRF reports. 1980, Ottawa: Traffic Injury Research Foundation of Canada. iv, 13.
19. Vuurman EF, et al. Seasonal allergic rhinitis and antihistamine effects on children's learning. Ann Allergy. 1993;71(2):121-126.
20. Woosley RL. Cardiac actions of antihistamines. Annu Rev Pharmacol Toxicol. 1996;36:233-252.
21. Tsai WC, Tsai LM, Chen JH. Combined use of astemizole and ketoconazole resulting in torsade de pointes. J Formos Med Assoc. 1997;96(2):144-146.
22. Honig PK, et al. Terfenadine-ketoconazole interaction. Pharmacokinetic and electrocardiographic consequences. JAMA. 1993;269(12):1513-1518.
23. Craft TM. Torsade de pointes after astemizole overdose. Br Med J (Clin Res Ed). 1986;(6521):660.
24. Snook J, et al. Torsade de pointes ventricular tachycardia associated with astemizole overdose. Br J Clin Pract. 1988;42(6):257-259.
25. Goss JE, Ramo BW, Blake K. Torsades de pointes associated with astemizole (Hismanal) therapy. Arch Intern Med. 1993;153(23):2705.
26. Suessbrich H, et al. Blockade of HERG channels expressed in Xenopus oocytes by the histamine receptor antagonists terfenadine and aste mizole. FEBS Lett. 1996;385(1-2):77-80.
27. Lindquist M, Edwards IR. Risks of non-sedating antihistamines. Lancet. 1997;349(9061):1322.
28. Atar S, et al. Torsades de pointes and QT prolongation due to a combination of loratadine and amiodarone. Pacing Clin Electrophysiol. 2003;26(3):785-786.
29. Kuchar DL, Walker BD, Thorburn CW. Ventricular tachycardia following ingestion of a commonly used antihistamine. Med J Aust. 2002;176(9):429-430.
30. Pinto YM, et al. QT lengthening and life-threatening arrhythmias associated with fexofenadine. Lancet. 1999;353(9157):980.
31. DuBuske LM. Second-generation antihistamines: the risk of ventricular arrhythmias. Clin Ther. 1999;21(2):281-295.
32. Wahn U, et al. Fexofenadine is efficacious and safe in children (aged 6-11 years) with seasonal allergic rhinitis. J Allergy Clin Immunol. 2003;111(4):763-769.
33. Simons FE. H1-recepor antagonists: safety issues. Ann Allergy Asthma Immunol. 1999;83:481-488.
34. Cobb DB, Watson WA, Fernandez MC. High-dose loratadine exposure in a six-year-old child. Vet Hum Toxicol. 2001;43(3):163-164.
35. Spiller HA, et al. Retrospective evaluation of cetirizine (zyrtec) ingestion. J Toxicol Clin Toxicol. 2002;40(4):525-526.
36. Hansen JJ, Feilberg NH Feilberg Jorgensen. [Accidental cetirizine poisoning in a four-year-old boy]. Ugeskr Laeger. 1998;160(41):5946-5947.
37. Ridout SM, Tariq SM. Cetirizine overdose in a young child. J Allergy Clin Immunol. 1997;99(6 Pt 1):860-861.
38. Frossard N, et al. Nasal effect of cetirizine and loratadine at 24 hours in patients with allergic rhinitis. Am J Ther. 1998;5(5):307-311.
39. Frossard N, et al. Onset of action in the nasal antihistaminic effect of cetirizine and loratadine in patients with allergic rhinitis. Allergy. 1997;52(2):205-209.
40. Simons FE, Johnston L, Simons KJ. Clinical pharmacology of the H1-receptor antagonists cetirizine and loratadine in children. Pediatr Allergy Immunol. 2000;11(2):116-119.
41. Grant JA, et al. A double-blind, single-dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in healthy male subjects. Allergy. 1999;54(7):700-707.
42. Simons FE, McMillan JL, Simons KJ. A double-blind, single-dose, crossover comparison of cetirizine, terfenadine, loratadine, astemizole, and chlorpheniramine versus placebo: suppressive effects on histamine-induced wheals and flares during 24 hours in normal subjects. J Allergy Clin Immunol. 1990;86(4 Pt 1):540-547.
43. Walsh GM. The effects of cetirizine on the function of inflammatory cells involved in the allergic response. Clin Exp Allergy. 1997;27 (suppl 2):47-53; discussion 54-56.
44. Fadel R, et al. In vivo effects of cetirizine on cutaneous reactivity and eosinophil migration induced by platelet-activating factor (PAF-acether) in man. J Allergy Clin Immunol. 1990;86(3 Pt 1):314-320.
45. Fadel R, et al. Inhibitory effect of cetirizine 2HCl on eosinophil migration in vivo. Clin Allergy. 1987;17(4):373-379.
46. Charlesworth EN, et al. Effect of H1 receptor blockade on the early and late response to cutaneous allergen challenge. J Pharmacol Exp Ther. 1992;262(3):964-970.
47. Greaves MW. Antihistamines. Dermatol Clin. 2001;19(1):53-62.
48. Bayramgurler D, et al. Effects of acrivastine, loratadine and cetirizine on histamine-induced wheal and flare responses. Clin Exp Dermatol. 1999;24(5):407-411.
49. Doherty V, et al. Treatment of itching in atopic eczema with antihistamines with a low sedative profile. BMJ. 1989;298(6666):96.
50. Markham A, Wagstaff AJ. Fexofenadine. Drugs. 1998;55(2):269-274; discussion 275-276.
51. Barecki ME, et al. In vitro characterization of the inhibition profile of loratadine, desloratadine, and 3-OH-desloratadine for five human cytochrome P-450 enzymes. Drug Metab Dispos. 2001;29(9):1173-1175.
52. Tarnasky PR, Van Arsdel PP Jr. Antihistamine therapy in allergic rhinitis. J Fam Pract. 1990;30(1):71-80.
53. Storms WW. Treatment of allergic rhinitis: effects of allergic rhinitis and antihistamines on performance. Allergy Asthma Proc. 1997;18(2): 59-61.
54. Sussman GL, et al. The efficacy and safety of fexofenadine HC1 and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis. J Allergy Clin Immunol. 1999;104(1):100-106.
55. Gillman SA, et al. The health-related quality of life effects of once-daily cetirizine HC1 syrup in children with seasonal allergic rhinitis. Clin Pediatr (Phila). 2002;41(9):687-696.
56. Grant JA, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol. 1995;95(5 Pt 1):923-932.
57. Yang YH, et al. A double-blind, placebo-controlled, and randomized study of loratadine (Clarityne) syrup for the treatment of allergic rhinitis in children aged 3 to 12 years. Asian Pac J Allergy Immunol. 2001;19(3):171-175.
58. Bronsky E, et al. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis. J Allergy Clin Immunol. 1995;96(2):139-147.
59. Bertrand B, et al. Cetirizine and pseudoephedrine retard alone and in combination in the treatment of perennial allergic rhinitis: a double-blind multicentre study. Rhinology. 1996;34(2):91-96.
60. Krause L, Shuster S. Mechanism of action of antipruritic drugs. Br Med J (Clin Res Ed). 1983;287(6400):1199-1200.
61. Finn AF Jr, et al. A double-blind, placebo-controlled trial of fexofenadine HC1 in the treatment of chronic idiopathic urticaria. J Allergy Clin Immunol. 1999;104(5):1071-1078.
62. Nelson HS, Reynolds R, Mason J. Fexofenadine HC1 is safe and effective for treatment of chronic idiopathic urticaria. Ann Allergy Asthma Immunol. 2000;84(5):517-522.
63. Leung DY. Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol. 2000;105(5):860-876.
64. Brinkman L, et al. Bronchial and skin reactivity in asthmatic patients with and without atopic dermatitis. Eur Respir J. 1997;10(5):1033-1040.
65. Warner JO. A double-blinded, randomized, placebo-controlled trial of cetirizine in preventing the onset of asthma in children with atopic dermatitis: 18 months' treatment and 18 months' posttreatment follow-up. J Allergy Clin Immunol. 2001;108(6):929-937.